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ABSTRACT 
Objectives: The present investigation was aimed to fabricate Camptothecin loaded Poly (Methacyclic acid-co-methyl-methyacrylate) nanoparticles 
to characterize the prepared nanoparticles and to evaluate the cytotoxicity of prepared Camptothecin. 
Methods: Camptothecin loaded polymeric nanoparticles were prepared by nanoprecipitation method by sonication approach. The prepared 
nanoparticles were evaluated for particle size, particle size uniformity, surface area, zeta potential, surface morphology, encapsulation efficacy, drug 
loading and in-vitro drug release. To evaluate the potential anticancer efficacy of nanoparticulate system, in-vitro cytotoxicity studies on human 
colon cancer cell line (HT-29) were carried out using MTT assay. 
Results: Camptothecin loaded polymeric nanoparticles were successfully prepared by nano precipitation method using sonication approach. 
Nanoparticles prepared using sonication method were with an average particle size 100 to 200 nm, particle size uniformity found to be<0.3 and 
zeta potential>20mV. Prepared Camptothecin loaded polymeric nanoparticles were spherical in shape and showed excellent encapsulation 
efficiency and drug loading. The release profile was found to be pH dependent. It was observed that polymer coated Camptothecin nanoparticles 
gave no release in simulated gastric fluid, negligible release in simulated intestinal fluid and maximum release in colonic environment. The drug 
release followed Hixson Crowell cube root law model. Prepared Camptothecin loaded polymeric nano formulations displayed enhanced cytotoxicity 
against HT-29 cells in comparison with pure Camptothecin.  
Conclusion: In summary, Camptothecin loaded Poly (Methacyclic acid-co-methyl-methyacrylate) nanoparticles may be considered as an attractive 
and promising formulation. Thus, the results indicate the potential for in-vivo studies for the developed pH sensitive nanoparticles of Camptothecin 
to establish their clinical application. 
Keywords: Camptothecin, Cytotoxicity, Drug release, MTT assay, Nanoparticles, Particle size. 
 
INTRODUCTION 
Colon cancer is a multifunctional disease related with high 
morbidity and mortality in western countries. The death rate of 
peoples with colon cancer around the world is about 715000 every 
year and is rising steadily over time [1, 2]. Most chemotherapeutic 
approaches available now-a-days are intended to treat the cancer 
are non-specific and are associated with various toxicities to healthy 
cells in addition to tumor cells [3]. The concept of colon targeting of 
active drug delivery is attractive because after the conventional oral 
administration the drugs are aimed at increasing its aqueous 
solubility, reduction in the stomach and intestine degradation and to 
achieve site specific delivery [4-6]. Colon targeted drug delivery 
would ensure directs treatment at the disease site, lowering the dose 
and reducing the systemic side effects [4, 7]. 
Camptothecin (CPT) naturally occurring quinolone alkaloids shows a 
significant anticancer activity with a broad spectrum of human 
malignancies. Camptothecin is an inhibitor of the DNA-replicating 
enzyme topoisomerase I which is believed to act by stabilizing a 
topoisomerase I-induced single strand break in the phospho diester 
backbone of DNA, thereby preventing relegation. Despite of its 
promising activity, the clinical applications are hampered by its poor 
water solubility, low stability in physiological medium, severe systemic 
toxicity and low antineoplastic activity [8]. Accordingly, a novel drug 
delivery system is imperative to overcome the internal defects. In recent 
years, a nano structured materials such as nano particles have been 
considered as potential carriers for hydrophobic drug delivery that may 
resolve the aforementioned problems [9, 10].  
Now-a-days, significant research has been done using nanoparticles as 
an oral drug delivery vehicle. Polymeric nanoparticles are actively 
investigated as drug carriers to reduce drug toxicity and degradation, 
so as to deliver therapeutic agents to several sites of action, to 
promote stable, selective and specific targeted therapy [11, 12].  
However, recent development in the field has rekindled interest in 
targeting approach [13]. Colon targeted delivery system of 
Camptothecin includes coating with pH dependent polymer, 
formulation of the timed release system, use of the pro drug, 
exploitation of carriers that degrade specifically by colonic bacteria 
and bioadhesive system [4]. In the present investigation, an attempt 
has been made to formulate Camptothecin loaded nanoparticles 
using a pH dependent polymer to deliver Camptothecin to the colon. 
Poly (Methacyclic acid-co-methyl-methyacrylate), a pH dependent 
enteric polymer which does not dissolve in the stomach and 
intestine pH, but dissolves in colonic pH due to ionization of its 
carboxyl functional group was used to selectively deliver the drug to 
colon [14]. Therefore the polymer protects drug from degradation in 
the stomach and intestine and the dosage form increase the 
solubility of the drug, sustain the drug release and protects the drug 
from degradation from the colonic environment [1, 4]. 
The present investigation was aimed to prepare Camptothecin 
loaded nanoparticles and characterization of the prepared 
nanoparticles such as particle size, particle size uniformity, surface 
area, zeta potential, surface morphology, encapsulation efficiency, 
drug loading and in-vitro drug release behavior. In addition, cell 
culture studies were conducted in order to evaluate the cytotoxicity 
of prepared Camptothecin on HT-29 cell line. 
MATERIALS AND METHODS 
Materials 
Camptothecin was commercially purchased from S. M Herbals, India. 
β-cyclodextrin and poloxamer (Grade 188) were procured from 
Sigma Aldrich, India. Poly (methacylic acid-co-methyl 
methyacrylate) was obtained from Evonik Industries, India. 
Dimethyl sulphoxide and propanol were obtained from E-Merck 
specialities Pvt. Ltd., Mumbai, India. 3-(4,5–dimethyl thiazol–2–yl)–
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5–diphenyl tetrazolium bromide (MTT), Fetal Bovine serum (FBS), 
Phosphate Buffered Saline (PBS), Dulbecco’s Modified Eagle’s 
Medium (DMEM) and Trypsin were obtained from Sigma Aldrich Co, 
St Louis, USA. EDTA, Glucose and antibiotics from Hi-Media 
Laboratories Ltd., Mumbai. All other chemicals and reagents used 
were of analytical grade and used without further purification. 
Methods 
Fabrication of polymeric nanoparticles 
Drug loaded polymeric nanoparticles were prepared by a novel 
nanoprecipitation method. However, this method is reported to 
yield nanoparticles with broad distribution [15]. Hence, few 
modifications to the conventional nanoparticles method were 
implemented to yield narrow particle size distribution [16]. Poly 
(methacylic acid-co-methyl methyacrylate) based nanoparticles 
drug delivery system was developed using the nanoprecipitation 
method by sonication method (table 1). 
Briefly, about 100 mg of Poly (methacylic acid-co-methyl 
methyacrylate) polymer with 10 mg of Camptothecin were 
dissolved in 10 ml of dimethyl sulphoxide, which was transferred 
at once into 25 ml of distilled water containing 62.5 mg of β-
cyclodextrin and 125 mg of poloxamer 188 under the sanction 
(Ultrasonic cleaner, Lark). Drug loaded nano particles were 
formed spontaneously but the sonication process was continued 
for 50 min [17]. The formulation was stored at refrigerated 
condition until further use. 
 
Table 1: Fabrication of drug loaded polymeric nanoparticles using sonication approach 
Trials A (mg) B (mg) C (mg) D (mg) E (ml) F (ml) G (mins) 
1 10 100 62.5 125 10 25 50 
A: Concentration of Drug; B: Concentration of Polymer 100; C: Concentration of β-Cyclodextrin; D: Concentration of Poloxamer 188; E: Volume of 
Organic Phase; F: Volume of Aqueous Phase; G: Sonication Duration. 
 
Characterization of prepared polymeric nanoparticles 
Particle size, particle size uniformity, surface area and zeta 
potential 
The average particle size, particle size uniformity and surface area of 
prepared Poly (methacylic acid-co-methyl methyacrylate) 
nanoparticles were measured based on laser light scattering 
principle using master sizer (Malvern Instrument, UK). Briefly, 
prepared Camptothecin loaded polymeric nano particle 
formulations was added drop wise into the water maintained in the 
sample dispersion unit of particle size analyzer, where the 
nanoparticles scattered using simple shaft pump a stirrer and 
recirculated continuously around the measurement zone of particle 
size analysis. The experiments were performed in triplicate [18]. 
Zeta potential of prepared polymeric nanoparticles was measured 
using the Zetasizer (ZEN3600, Malvern). Aggregation of 
nanoparticles in formulation reduces the physical stability of 
nanosuspension and leads to decreased oral bioavailability. The 
charge on the nanoparticles play a significant role in aggregation. 
Higher number of either positive or negative charge repels each 
other which in turn prevents aggregation. Zeta potential around±30 
mV was considered acceptable [19]. Briefly, about 1 ml of polymeric 
nanoparticles was diluted approximately using ultra-pure water 
(Milli Q Academic Milli Pore). Diluted samples were loaded 
separately in a disposable zeta cell and measured for zeta potential.  
Particle surface morphology analysis 
The morphological examination of the prepared polymeric 
nanoparticles was performed by Field Emission Scanning Electron 
Microscopy (FESEM) and Transmission Electron Microscopy (TEM). 
FESEM (Hitachi SU 660) was used to analyze the morphology by an 
accelerating voltage of 15 kV. The spot size in FESEM is smaller than 
conventional SEM and it can produce a very high resolution image. 
The TEM is also used to analyze the shape of the prepared 
nanoparticles. Briefly, the prepared Camptothecin loaded polymeric 
nanoparticles were dropped onto Formvar-coated copper grids and 
air dried. The samples were then negatively stained with 1% uranyl 
acetate for 10 min and air dried again. The samples were then 
imaged using transmission electron microscope (Hitachi H7500, 
India) at 20 000 magnifications [18]. 
Encapsulation efficiency and drug loading estimation 
Camptothecin loaded polymeric nano formulations were centrifuged 
using a cooling centrifuge (C-24, Remi) for 45 min at 19000 rpm at-
20 °C and supernatant was separated. To 1 ml of supernatant, an 
equal volume of methanol was added[20]and sonicated (Ultrasonic 
cleaner, Lark) for 5 min followed by filtration through 0.45 µm 
membrane. Samples were analyzed using the developed HPLC 
methods as mentioned below. Estimated amount of free drugs was 
expressed as Wfree
For the analysis, Shimadzu HPLC system was used with the best 
chromatographic conditions equipped with C18 column (ODS 250 mm X 
4.6 mm with 5 micron pore size, Phenomenax) using a mobile phase 
combination of 0.5% W/V of ammonium acetate aqueous solution and 
acetonitrile (85:15, v/v) in an isocratic mode elution with a flow rate of 1 
mlmin-1 at the column oven temperature of 35 °C and the samples were 
analyzed by PDA detector at a wavelength of 368 nm [22-24]. 
. The experiments were performed in triplicate.  
Encapsulation efficiency (EE) and drug loading (DL) were estimated 
as follows  
 
EE (%) =
[Drug Content (Wtotal)]– [Drug in the supernatant (Wfree)]
[Drug Content (Wtotal)]
 × 100  
 
DL (%) =
[Drug Content (Wtotal)]– [Drug in the supernatant (Wfree)]
[Weight of the polymer used in the formulation (Wpolymer)]
 × 100 
 
In-vitro drug release study 
The release characteristics of Camptothecin from the prepared 
nanoparticle formulation were investigated using USP dissolution 
apparatus 2 (Electrolab, Mumbai, India) maintained at 37◦C±0.5◦C 
with a rotating speed of 100 rpm. To achieve simulated 
gastrointestinal transit condition the release profile of nano 
formulation was studied with the dissolution medium of changing pH 
at various time intervals. Initially, the dissolution medium was 
maintained at pH 1.2 with 350 ml of 0.1N HCl for 0-2 h. At the end of 
the second hour, the pH of the dissolution medium was raised to 4.5 by 
the addition of 250 ml of solution composed of 3.75 g of KH2PO4 and 
1.2 g of NaOH and the total volume of dissolution medium was 600 ml. 
At the end of the fourth hour, pH of the medium was raised to 7.4 by 
addition of 300 ml of phosphate buffer concentrate (2.18 g of KH2PO4
The data obtained from in-vitro release studies were kinetically analyzed 
to find out the mechanism of drug release rate kinetics of the dosage 
form. The obtained data were fitted with the zero order, First order, 
Higuchi, Hixson-Crowell erosion equation, Korsmeyer-Peppas equation. 
 
and 1.46 g of NaOH in distilled water) [25, 26]. At predetermined time 
intervals, 5 ml of sample was withdrawn and replaced with fresh 
dissolution media. The collected samples were filtered through 0.45 
µm membrane filter (Millipore). After appropriate dilution, the 
concentration of drug in the sample was analyzed using HPLC. 
In-vitro cytotoxicity studies 
Cell line and culture medium 
Prepared polymeric nano formulation was evaluated for cytotoxicity 
using (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
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(MTT) assay on HT-29 (Human colon carcinoma) [27]. HT-29 (Human 
colon carcinoma) cell line was procured from National Centre for Cell 
Sciences (NCCS), Pune, India. Stock cells were cultured in DMEM 
supplemented with 10% inactivated Fetal Bovine Serum (FBS), 
penicillin (100 IU/ml), streptomycin (100 g/ml) and amphotericin B 
(5 g/ml) in a humidified atmosphere of 5% CO2 at 37◦C until 
confluent. The cells were dissociated with a TPVG solution (0.2% 
trypsin, 0.02% EDTA, 0.05% glucose in PBS). The stock cultures were 
grown in 25 cm2 culture flasks and all experiments were carried out in 
96 microtitre plates (Tarsons India Pvt. Ltd., Kolkata, India). 
MTT assay 
The monolayer cell culture was trypsinized and the cell count was 
adjusted to 1.0 x 105 cells/ml using DMEM containing 10% FBS. To 
each well of the 96 well microtitre plate, 0.1 ml of the diluted cell 
suspension (approximately 10 000 cells) was added. After 24 h, 
when a partial monolayer was formed, the supernatant was flicked 
off, wash the monolayer once with medium and 100 µl of different 
test concentrations of test drugs, subsequent concentrations of 
DMSO (1000, 500, 250, 125 and 62.5%) maintained as control was 
added on to the partial monolayer in microtitre plates. The plates 
were then incubated at 37oC for 3 d in 5% CO2 atmosphere, and 
microscopic examination was carried out and observations were 
noted every 24 h intervals. After 72 h, the drug solutions in the wells 
were discarded and 50 µl of MTT in PBS was added to each well. The 
plates were gently shaken and incubated for 3 h at 37oC in 5% CO2
Camptothecin loaded Poly (Methacyclic acid-co-methyl-
methyacrylate) nanoparticles were prepared based on 
nanoprecipitation principle under the influence of sonication. 
 
atmosphere. The supernatant was removed and 100 µl of propanol 
was added and the plates were gently shaken to solubilize the 
formed formazan. The absorbance was measured using a microplate 
reader at a wavelength of 540 nm [28]. 
RESULTS AND DISCUSSION 
Colon cancer is being one of the most leading cancers and treating 
colon cancer can be most efficacious by the direct delivery of the 
drug to the affected area. This selective delivery also may reduce the 
dose of the therapeutic agent to be delivered [7]. Targeting to the 
colon relies on protecting the moiety to be targeted from being 
released in the stomach, at the same time exploring the unique 
features of the colon for maximizing the drug release [1]. 
In the present investigation, the pH-dependent approach was exploited 
for the specific delivery of Camptothecin to the colon. As mentioned 
earlier, the selective dissolution of Poly (Methacyclic acid-co-methyl-
methyacrylate) at the colonic pH by the ionization of its carboxylic 
functional groups was exploited to achieve the desired action.  
Fabrication of polymeric nanoparticles 
Organic phase contains Camptothecinand Poly (Methacyclic acid-co-
methyl-methyacrylate) in water miscible organic solventdimethyl 
sulphoxide. Aqueous phase contains poloxamer 188 as a surfactant 
and β-cyclodextrin as a stabilizer. Addition of organic phase in to 
aqueous phase under the influence of sonication results in rapid 
miscibility of dimethyl sulphoxide with water, which increases the 
polarity of the dimethyl sulphoxide and decreases the solubility of 
Camptothecin leading to initiation of crystal nucleation. 
Concurrently, sonication process produce bubbles, whose size is 
near the resonant size for the applied frequency and begins to 
oscillation on linearly and finally collapse resulting in production of 
extremely high temperature, high pressure and shockwave, which 
inhibits the crystal growth of Camptothecin. However, developed 
Camptothecin nanocrystals form complex with β-cyclodextrin, 
which increases the stability and solubility of Camptothecin in the 
aqueous phase. Negatively charged particles repel each other and 
develop an electrostatic force, which maintains the nanoparticles in 
Brownian motion and overcomes the Vander Waals force of 
attraction and gravitational force resulting in the prevention of 
nanoparticle aggregation and sedimentation. 
Particle size, particle size uniformity surface area and zeta 
potential 
After fabrication, prepared Camptothecin loaded polymeric 
nanoparticles were stored at room temperature for one month to 
identify any aggregation and post-formulation degradation. 
Prepared Camptothecin loaded polymeric nanoparticles were 
characterized for particle size, particle size uniformity, surface area 
and zeta potential as per the procedure mentioned above. The 
results were summarized in table 2 and characterization spectrum 
was displayed in fig.1 and fig.2. In sonication method, prepared 
polymeric nanoparticles have shown an average particle size of 150 
nm with particle size uniformity of 0.210, surface area of 51.7 m2g-1
 
 
and zeta potential of-21.8 mV. 
 
Fig. 1: Particle size spectrum of Camptothecin loaded polymeric 
nanoparticles prepared using sonication approach 
 
Table 2: Characterization of Camptothecin loaded polymeric nanoparticles 
Trial Average particle size (nm) Particle size uniformity Surface area (m2g-1 Zeta potential (mV) ±SD) 




Fig. 2: Zeta potential spectrum of Camptothecin loaded 
polymeric nanoparticles prepared using sonication approach 
Particle surface morphology analysis 
Particle surface morphology decides the basic function of particles, 
degradation, release of drug from polymer matrix, transport of 
particles in the body, internalization of the drug. Prepared 
Camptothecin loaded polymeric nanoparticles were imaged using 
field emission scanning electron microscopy (fig. 3) and 
transmission electron microscope (fig. 4). 
Prepared Camptothecin loaded polymeric nanoparticles were 
spherical in shape. Hence, Camptothecin encapsulated in the polymer 
matrix will also be in spherical shape and expected to enhance the 
basic function, release of Camptothecin from the polymer matrix, 
transport of Camptothecin in the body and internalization of 
Camptothecin by many folds than the free Camptothecin. 
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Fig. 3: Particle surface morphology of Camptothecin loaded 
polymeric nanoparticles prepared using FESEM 
 
 
Fig. 4: Particle surface morphology of Camptothecin loaded 
polymeric nanoparticles prepared using TEM 
 
Encapsulation efficiency and drug loading estimation 
The amount of Camptothecin encapsulated in polymeric 
nanoparticles determines the effectiveness of prepared 
nanoformulations. Hence, encapsulation efficiency and drug loading 
estimation were performed. The results were summarized in table 3. 
In sonication method, encapsulation efficiency and drug loading 
were found to be 92.85% and 9.12%. Sonication approach displayed 
excellent encapsulation efficiency and drug loading only an 
insignificant amount of Camptothecin were seen as a free drug. 
Hence, prepared Camptothecin loaded polymeric nanoparticles is 
expected to display superior pharmacological activities. 
 
Table 3: Encapsulation efficiency and drug loading of the 
prepared Camptothecin loaded polymeric nanoparticles 
Trial Encapsulation efficiency (%) Drug loading 
(%) 
1 92.85±0.40 9.12±0.17 
 (n=3) 
In-vitro drug release 
In-vitro drug release from the nanoparticles was assessed in 
simulated gastrointestinal conditions. The pH condition used was pH 
1.2 for a period of 2 h (stomach), pH 4.5 for 2 h (duodenum) 
followed by pH 7.4 (distal ileum and colon) for the remaining period 
of the study using a USP dissolution test apparatus (Apparatus type 
2) [29]. The cumulative percent drug release curve shows (fig. 5) 
that the drug release was less than 10% up to 4 h and the drug 
release increased when the pH of the medium was adjusted to 7.0.  
 
 
Fig. 5: In-vitro release profile of Camptothecin loaded polymeric 
nanoparticles(n=3) 
 
Poly (Methacyclic acid-co-methyl-methyacrylate) is an anionic 
polymer; the ratio of free carbonyl groups to the ester groups is 
approximately 1:2. It exhibits a dissolution threshold pH slightly 
above 7.2 [30]. Due to the pH sensitive property, it was selected to 
avoid the rapid dissolution of Camptothecin during the initial transit 
of the nanoparticles through gastric cavity and the upper small 
intestine. It was observed that polymer coated Camptothecin 
nanoparticles gave no release in the simulated gastric fluid, 
negligible release in the simulated intestinal fluid and maximum 
release in the colonic environment. 
Kinetic analysis of release data 
The results of in-vitro release profile obtained from the formulations 
were plotted to know the mechanism of drug release. The data were 
treated according to zero order release, first order release, Higuchi 
model, Korsemeyer-Peppas model and Hixson Crowell cube root 
law. The release rate kinetics data of the formulation is shown in 
table4. It is concluded that the formulation gave a good fit to the 
Hixson Crowell cube root law. The diffusion exponent (n) value was 
greater than 0.89, this result indicated that the release of drug from 
the polymer matrix formulations was found to be super case-II 
transport, i.e., drug release by both diffusion and relaxation of 
polymer chain. 
 
Table 4: Determination coefficients (r2) and release exponent (n) of kinetic data analysis of Camptothecin release from polymeric 
nanoparticles 








Hixson-Crowell cube root law r2 
r n 2 
1 0.7244 0.7198 0.629 0.515 1.4019 0.9317 
 
In-vitro cytotoxicity studies 
Prepared Camptothecin loaded polymeric nano formulations were 
studied for its in-vitro anticancer efficacy against human colon 
cancer HT-29 cell lines, and the results were summarized in table 5 
and fig. 6. 
Pure Camptothecin displayed very poor cytotoxicity on HT-29 cell at 
1000 µg/ml(CTC50:>1000 µg/ml). Camptothecin loaded polymeric 
nano formulation displayed good cytotoxicity on HT-29 cells at 1000 
µg/ml (CTC50: 155.00 µg/ml). However, prepared Camptothecin 
loaded polymeric nano formulations displayed enhanced cytotoxicity 
against HT-29 cells in comparison with pure Camptothecin. 
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Table 5: In-vitro cytotoxicity of prepared Camptothecin loaded polymeric Nanoparticles on HT-29 cells 
Sample Test concentration (µg/ml) % Cytotoxicity CTC50 (µg/ml) 














Fig. 6: In-vitro cytotoxicity of pure camptothecin (a) and camptothecin loaded polymeric nanoparticles (b) on HT-29 cells 
 
CONCLUSION 
Poly (Methacyclic acid-co-methyl-methyacrylate) nanoparticles was 
prepared using the nano precipitation method by sonication approach. 
Prepared plain and Camptothecin loaded polymeric nanoparticles 
were characterized for particle size, particle size uniformity, surface 
area and zeta potential. Nanoparticles prepared using sonication 
method were with an average particle size<100 nm, uniformity<0.3 
and zeta potential>20mV. Prepared Camptothecin loaded polymeric 
nanoparticles were spherical in shape. Hence, Camptothecin 
encapsulated in the polymer matrix will also be in spherical shape and 
expected to enhance the basic function, release of Camptothecin from 
the polymer matrix, transport of Camptothecin in the body and 
internalization of Camptothecin by many folds than the free 
Camptothecin. Sonication approach displayed excellent encapsulation 
efficiency and drug loading and only an insignificant amount of 
Camptothecin were seen as a free drug. Hence, prepared 
Camptothecin loaded polymeric nanoparticles is expected to display 
superior pharmacological activities. It was observed that Poly 
(Methacyclic acid-co-methyl-methyacrylate) coated Camptothecin 
nanoparticles gave no release in the simulated gastric fluid, negligible 
release in the simulated intestinal fluid and maximum release in the 
colonic environment. It is concluded that the formulation gave a good 
fit to the Hixson Crowell cube root law. Prepared Camptothecin loaded 
polymeric nanoparticles were studied for its in-vitro anti-cancer 
efficacy against human colon cancer cells using MTT assay. Prepared 
Camptothecin loaded polymeric nano formulations displayed 
enhanced cytotoxicity against HT-29 cells in comparison with pure 
Camptothecin. Thus, the results indicate the potential for in-vivo 
studies of the developed pH sensitive nanoparticles of Camptothecin 
to establish their clinical application. 
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